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Thus when the clinical picture is at all suggestive of
hypoglycaemia, blood should be taken for sugar estima-
tion, and intravenous glucose administered on admission
of the patient, without awaiting the laboratory results.
Brain Tumours-3 Cases
The diagnosis of a brain tumour as the cause of the
convulsions was first suspected in 3 patients upon the
discovery of severe papilloedema and raised cerebrospinal
fluid pressure. The importance of a careful ophthalmosco-
pic examination in all patients presenting with convulsions
is illustrated by these cases.
The pregnant state causes a deterioration of the symp-
wms caused by angiomas and meningiomas, but there is
regression between pregnancies. The more malignant glio-
mas seem to grow with special rapidity in pregnancy, but
this is merely an impression for their behaviour is so
variable at all times. Increased cerebral oedema in preg-
nancy appears to bring on the symptoms of a brain
tumour at an earlier date than would otherwise have
occurred.
The management of a patient with a brain tumour in
pregnancy is usually carried out without regard for the
pregnant state, and neurosurgery is performed where
indicated.
CONCLUSION
The importance of bringing to the pregnant woman with con-
vulsions the same degree of clinical acumen and meticulous
investigation as to the non-pregnant patient, is obvious from
this study. The hurried assumption that all are eclamptic can
easily be responsible for preventable maternal deaths.
I wish to thank Prof. D. Crichton for his advice and encou-
ragement in the preparation of this paper; Dr. J. McKechnie
for his assistance; and Dr. H. Wannenburg, Medical Superin-
tendent of King Edward Vln Hospital, for permission to
publish.
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EXFOLIATIVE CYTOLOGY IN THE PROGNOSIS OF MALIGNANT DISEASE OF THE
UTERINE CERVIX TREATED BY IONIZING RADIATION
G. W. WUCE.LEY, F.R.M.S., Chief Medical Technologist, Pathology Laboratory Service, Nalal Provincial
Administration, and Cytotechnologist, Addington Hospital, Durban
The present pOSItIOn of exfoliative cytology in the prog-
nosis of malignant disease of the uterine cervix treated by
ionizing radiation is not clear.
RADIATION CHANGES OCCURRING IN BENIGN CELLS
The appearance of cellular changes subsequent to irradia-
tion is a well-known phenomenon and the changes have
been fully described. Vacuolation of the cytoplasm, in-
creased cell size, increased nuclear size and multinuclea-
tion are changes which have been recorded in benign
cells. Parabasal and basal cells often show considerable
vacuolation, which led Graham and Graham' to suggest
that these changes could have a prognostic value. They
postulated that the degree of change would be indicative
of the sensitivity of the tumour to irradiation, 'RR' or
radiation response being the percentage of cells showing
radiation changes. Routine staining by the Papanicolaou
method, using Harris' haematoxylin, often shows the
nucleus as an even, glassy, slate-blue structure.
Vacuolation of the cytoplasm is perhaps too often
ignored as a degenerative change and attention focussed
solely on nuclear changes. Vacuolation is a manifestation
of a disordered metabolism following upon irradiation,
possibly the visible result of faulty nucleic acid synthesis.'
It is possibly, in part, caused by RNA transfer from
cytoplasm to nucleus. Gusberg,' using specific nuclear
staining to evaluate cytochemical changes, suggested that
a good response to irradiation was shown if the trend
was towards a higher percentage of B cells (relatively
rich in RNA) with a decrease in A cells (relatively rich
in DNA) and cells in mitosis. Radiation has been shown
to inhibit DNA synthesis while having little effect on
RNA activity. Atkin4 has reported a relationship be-
tween nuclear size and prognosis following radiotherapy
based on nuclear measurement and DNA estimations on
Feulgen-stained sections of cervical tumours.
Increased cell size and multinucleation with juxtaposi-
tion of macro- and micronuclei within the same cell border
are visible signs of chromosomal aberration. A study of
irradiation changes by time lapse photography' has shown
that fibroblasts entering mitosis 15 - 20 hours after irra-
diation often remained in this state for very long periods
and, in fact, seldom completed the process of division.
Multinucleated giant epithelial cells were often the result
of such abortive mitoses.
As a result of irradiation, chromosome breakages may
occur and chromosomal abnormalities develop in meta-
phase cells. Breakages may occur even in the more radio-
resistant cells such as nerve and bone cells. Usually these
latter will continue to function normally. Where cells
ultimately divide weeks, months or even years later the
damage will become apparent. This fact partly explains
one of the most puzzling aspects of post-irradiation cyto-
logy, the appearance of bizarre irradiation changes in
smears taken many years after the end of treatment.
RADIATION CHANGES OCCURRING IN MALIGNANT CELLS
Malignant cells after irradiation therapy are often bizarre
in the extreme, but their appearance may be more fully
understood if attention is paid to the characteristics of
the malignant cells, particularly in regard to the nucleus.
In considering the criteria of malignant cells stress is
usually placed upon hyperchromatism, but hypochroma-
tism should not be disregarded. In uterine neoplasms it is
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Fig. 1. Typical record of a patient with vault recurrence.
KI complicated by the administration of a cardiac gluco-
side which may have had an oestrogen-like stimulation.
cervical stump. Follow-up smears were negative until
February 1962 when cells which were interpreted as
malignant were found. Vault biopsy in May 1962 was
reported as 'malignant change restricted to the epithelium'.
Further radiation treatment was given in June 1962, but
her smears remained persistently positive until her death
from coronary thrombosis in June 1965. Unfortunately
no postmortem examination was performed so that further
histological examination of the vaginal wall was not
possible.
THE USE OF CYTOLOGY IN THE DIAGNOSIS OF
RECURRE 'T CARCINOMA
The appearance of malignant cells in vaginal smears,
months or years after treatment, is often the earliest sign
of recurrent disease and frequently precedes the appear-
ance of clinical evidence by a considerable period of
time. Fig. 1 shows the typical record of such a case. The
patient had a sub-total hysterectomy in 1932 and was
subsequently treated, in 1960, for a carcinoma of the
SUMMARY
In this brief review an attempt has been made to focus
attention on the problems which may be encountered during
the cytological follow-up of patients treated by ionizing
radiation for malignant disease of the uterine cervix. It is
suggested that profitable approaches to the problem of prog-
nosis may be made by concentrating on the cytochemical and
cytogenetic constituents of cervical tumours; and that the
karyopyknotic index may prove to be an easily performed and
reliable test for the early detection of recurrent carcinoma.
months aftC?r irradiation
I am grateful to Prof. T. Sacks, Department of Radiology,
University of Tatal, and to the staff of the combined Gynae-
malignant disease indicates persistence of the disease. It
was postulated that tumours produce oestrogen or oestro-
gen-like substance and that the removal by surgery or the
destruction by irradiation of viable tumour tissue would
lead to a drop in the KI. Failure of the treatment would
be shown by a continuing high index.
A possible complication arises from the fact that digi-
toxin and other cardiac glucosides display an oestrogen-
like activity. It is possible that they are converted, in vivo,
into oestrogenic compounds.'" It is important that the full
therapeutic regimen of the patient be made available to
the cytologist.
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not unusual for cells to possess fewer than 46 chromo-
somes. In gastric cancer it is fairly common' and this
accounts for one of the difficulties encountered in the
interpretation of gastric smears when no obviously hyper-
chromatic cells are present.
Many of the cells will however possess many more than
46 chromosomes and will be seen as hyperchromatic cells.
The number of chromosomes present appears to be related
to the radiosensitivity of the tumour.' It is probable that
tumours with an average of more than 60 chromosomes
will be radio-resistant and those with fewer than 60 will
be radio-sensitive.
In malignant cells, following upon irradiation, changes
similar to those found in benign cells will occur. Mitosis
is interfered with and bizarre forms appear in the smears.
Multinucleated giant epithelial cells \vhose nuclei appear
as intense, solid, slate-coloured masses, are seen together
with pale, ghostly forms.
PROG OSTIC VALUE OF POST-IRRADlATIO PHENOMENA
Can these post-irradiation phenomena be utilized in tests
for the prognosis of malignant disease?
This question has been debated at some length and
there have been numerous proposals for their utilization.
Tumour and host characteristics before treatment have
been studied"" as have tumour and host response during
therapy."-"
Tests following treatment, such as assessment of tumour
status by biopsies performed at the conclusion of treat-
ment" and a combination of histo-cytochemical tests"
have also been suggested. Graham and Graham introduced
the concept of SR (sensitization response) in the pre-
treatment smear-i.e. host response to the tumour-and
RR (radiation response)-i.e. tumour-host response to
irradiation-utilizing the changes found in the basal layers
as indications of response.
Many workers supported this concept while many others
failed to corroborate their findings. The over-all picture
tends to suggest that SR is not a reliable prognostic index
as its validity is obviously affected by the endocrine state
of the patient." A good SR is more frequent in postmeno-
pausal women than in those in younger age-groups. In our
admittedly limited experience, RR has not proved to be
a reliable indicator. A different approach was made by
Wachtel," who observed an association between malignant
growths of the uterus and an abnormally high cornification
or karyopyknotic index after. the cessation of normal
ovarian function in natural, surgical or post-irradiation
menopause, and suggested that this could be used as a
simple prognostic test.
The karyopyknotic index (KI) is defined as the percent-
age of squamous cells with pyknotic nuclei. It is regarded
as the manifestation of the patient's oestrogen level since
normally ovulating women reach peak value of cornifica-
tion at ovulation and oestrogen administered to postmeno-
pausal women raises the cornification value. KI is esti-
mated by counting the percentage of cells with pyknotic
nuclei among 200 unselected superficial and intermediate
cells, although parabasal cells may, in severe inflammation,
show nuclear pyknosis. Basal cells are ignored in this
estimation. Observations on a small group of patients
suggested that the finding of a high KI after treatment for
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cology /Radiotherapy Clinic for their cooperation; and to the
Chief Pathologist, Pathology Laboratory Services, Natal Pro-
vincial Administration, for permission to publish.
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SUID-AFRIKAANSE VERENIGING VAN VERLOSKUNDIGES EN GINEKOLOE (M.V.s.A.)
soum AFRICAN SOCIETY OF OBSTETRICIANS AND GYNAECOLOGISTS (M.A.S.A.)
PRYS IN OBSTETRIE EN GINEKOLOGIE
n prys van R50 sal in die eerste instansie toegeken word.
Voorwaardes van Toekennin/?
Registrateurs, huisdokters en geregistreerde mediese prakti-
syns wat nie op die spesialiste-register is nie, insluitende die
wat in opleiding is in obstetrie en ginekologie, sal in aanmerk-
ing kom vir die toekenning.
Referate wat by 'n S.A.V.V.G. Kongres of by die afdeling
Obstetrie en Ginekologie van 'n Kongres van die Mediese Ver-
eniging van Suid-Afrika voorgedra word, sal in die eerste
instansie in aanmerking kom.
Tndien geen toekenning in hierdie afdeling gemaak word
nie, sal obstetriese en/ of ginekologiese publikasies wat gepubli-
seer is gedurende die jaar wat die Algemene Vergadering van
die S.A.V.Y.G. voorafgegaan het, in aanmerking kom.
Keuring
Die keuring van die kandidaat wat die toekenning ontvang,
sal deur die Raad van die S.A.V.V.G. gedurende die tydperk
van die Kongres gemaak word. Hierdie Komitee sal die mag
he om lede te ko-opteer om hulle by te staan in die keuring.
Die besluit van die Komitee sal finaal wees. Die President van
die S.A.V.V.G. of enige ander persoon wat deur die Raad
benoem word, sal aan die einde van die Kongres die Prys
oorhandig.
Die toekenning sal nie gemaak word indien daar geen refe-
raat van voldoende gehalte is nie, en in die geval sal die Prys
[eruggehou word vir toekenning op 'n later stadium of dit sal
toegeken word aan 'n kandidaat wat spesiale navorsing doen
\Vat ondersteuning waardig geag word. 'n Toekenning mag
aan meer as een kandidaat gemaak word indien die referaat
van voldoende gehalie beskou word. Enige referaat wat by 'n
Kongres die toekenning verower moet aan 'n erkende mediese
tydskrif voorgele word vir publikasie.
Aansoeke
Alle aansoeke (dit sluit referate in wat by die Kongres ge-
lewer gaan word) moet die Ere-Sekretaris van die S.A.V.V.G.
nie minder as 30 dae voor die Algemene Vergadering van die
Vereniging bereik.
421 Trust Bank Centre
Central Street
Pretoria




Ere-Sekretaris: SA. V. v.G.
PRIZE IN OBSTETRICS AND GYNAECOLOGY
A Prize of R50 will be awarded in the first instance.
Conditions of A ward
Registrars, house surgeons and registered medical p~a~ti­
tioners not on the specialist register, including those in trallIng
for specialization in obstetrics and gynaecology, shall be elig-
ible for the award.
Papers read at a S.A.S.O.G. Congress or the Obstetrical
and Gynaecological section of M.A.S.A. Congress shall be
considered in the first instance.
Should no award be made in this category, obstetrical and/
or gynaecological papers published during the year preceding
the Annual General Meeting of the S.A.S.O.G. shall then be
considered.
Selection
The selection of the candidate to receive the award shall be
made by the Council of S.A.S.O.G. during the Congress. This
Committee will have the power to co-opt members to assist in
the selection. The decision of the Committee will be final. The
President of S.A.S.O.G. or other nominee of the Council shall
present the Prize at the end of the Congress.
The award will not be made if there is no paper of sufficient
merit, in which case the Prize will be retained for award at a
later stage or awarded to a candidate doing special research
work which is considered to be worthy of support. An award
may be made to more than one candidate if the paper is con-
sidered to be of sufficient merit. Any paper awarded the Prize
at a Congress must be submitted for publication in a recog-
nized medical journal.
Applications
All applications (this includes papers to be read at Congress)
to be made to the Hon. Secretary, S.A.S.O.G. 1 month (30
days) before the Annual General Meeting of the Society.
P. M. Bremer
HOIl. Secretary: S.A.S.O.G.
IN DIE VERBYGAAN : PASSING EVENTS
Universiry of Cape Town and Association of Surgeons of South
Africa (M.A.S.A.), Joinr Lecfllres. The next meeting will be
Kliniese besprekings word ook gereeld om 9.00 vm. elke
Saterdagoggend gehou in die Groot Voorlesingsaal, Karl
Bremer-hospitaal, en is oop vir bywoning deur dokters.
Universireit van Srellellbosch en Karl Bremer-hospitaal,
Klinies-patologiese Besprekings. Die volgende vergadering vind
plaas op Dinsdagmiddag 7 Junie om 4.30 nm. in Lesingkamer 2,
Farmokologiegebou, Karl Bremer-hospitaal, Bellville. Die ver-
gadering sal die vorm van 'n klinies-patologiese konferensie
neem, en alle dokters wat belang stel, word vriendelik uitgenooi
om die vergadering by te woon.
* * *
